X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 59 filers reported holding X4 PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,000 | 0.0% | 18,043 | +76.1% | 0.00% | – |
| Q2 2023 | $20,000 | – | 10,243 | +10041.6% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 101 | -95.1% | 0.00% | – |
| Q2 2021 | $13,000 | -13.3% | 2,064 | +19.7% | 0.00% | – |
| Q1 2021 | $15,000 | +150.0% | 1,724 | +96.8% | 0.00% | – |
| Q4 2020 | $6,000 | – | 876 | +2725.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 31 | -69.6% | 0.00% | – |
| Q1 2020 | $1,000 | -90.0% | 102 | -89.0% | 0.00% | – |
| Q4 2019 | $10,000 | +233.3% | 930 | +241.9% | 0.00% | – |
| Q3 2019 | $3,000 | – | 272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |